Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Praziquantel for Female Genital Schistosomiasis
NCT04115072Phase 3Completed
- Sponsor
- Regionshospital Nordjylland
- Start
- Sep 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of praziquantel in Female Genital Schistosomiasis (FGS), sponsored by Regionshospital Nordjylland. Started Sep 2019; status: completed.
02
Drugs
praziquantel
03
Conditions
Female Genital Schistosomiasis (FGS)
Beyond the preview
Go deeper on NCT04115072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04115072.